Adjuvant toripalimab for locally advanced head and neck squamous cell carcinoma patients who achieved pathological complete response after neoadjuvant immunochemotherapy and surgery: A single-arm, phase II trial

被引：0
|
作者：
Chen, S. [1 ]
Yan, S. [1 ]
Hu, W. [2 ]
Lin, Q. [1 ]
Zhou, J. [3 ]
Chen, W. [1 ]
Liu, X. [1 ]
Guo, Z. [1 ]
Zhang, X. [1 ]
Yang, C. [1 ]
Gao, X. [1 ]
Li, M. [1 ]
Li, X. [1 ]
Zhang, S. [1 ]
Zhang, Y. [1 ]
Zhang, Q. [1 ]
Yang, A. [1 ]
Song, M. [1 ]
机构：
[1] Sun Yat Sen Univ Canc Ctr, Dept Head & Neck Surg, Guangzhou, Peoples R China
[2] Sun Yat Sen Univ Canc Ctr, Dept Pathol, Guangzhou, Peoples R China
[3] Sun Yat Sen Univ Canc Ctr, Radiol, Guangzhou, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.08.927
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
865P
引用
收藏
页码：S622 / S622
页数：1
相关论文
共 50 条
  • [31] Multi-omics analysis of tislelizumab plus nab-paclitaxel and cisplatin as neoadjuvant immunochemotherapy for locally advanced hypopharyngeal squamous cell carcinoma: A prospective single-arm phase II trial
    Xie, Z.
    Zhang, W.
    Chen, X.
    Wang, X.
    Liu, S.
    Yi, J.
    An, C.
    Lu, H.
    Yao, J.
    Zhu, H.
    Xie, T.
    Tang, L.
    He, X.
    Shi, Y.
    Gui, L.
    ANNALS OF ONCOLOGY, 2024, 35 : S641 - S641
  • [32] Neoadjuvant immunochemotherapy for locally advanced hypopharyngeal squamous cell carcinoma: Pooled results analysis from two prospective single-arm phase 2 trials
    Gui, Lin
    Xie, Zucheng
    Wang, Xiaolei
    Liu, Shaoyan
    Yi, Junlin
    An, Changming
    Chen, Xinrui
    Shi, Yuankai
    He, Xiaohui
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [33] Neoadjuvant anlotinib combined with penpulimab for resectable locally advanced esophageal squamous cell carcinoma (ESCC): A prospective, single-arm, phase II trial.
    Chen, Yueyun
    Ding, Zhen-Yu
    Yuan, Yong
    Yang, Yu-Shang
    Lin, Zhen
    Tian, Jiangfang
    Liu, Ting
    Yue, Zheng
    Shi, Hua-Shan
    Hu, Yang
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 352 - 352
  • [34] Camrelizumab plus apatinib as induction therapy for locally advanced head and neck squamous cell carcinoma (IMplus): A single-arm phase II study.
    Ye, Lulu
    Zhang, Lin
    Li, Rongrong
    Dou, Shengjin
    Jiang, Wen
    Zhu, Guopei
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [35] Safety and efficacy of neoadjuvant therapy with tislelizumab plus chemotherapy for locally advanced head and neck squamous cell carcinoma: a single-arm, retrospective study
    Liang, Haifeng
    Liang, Wenting
    Tian, Jiawang
    Zheng, Shibei
    Su, Yangzhou
    Huang, Piao
    Chen, Renhui
    Guan, Zhong
    Cai, Qian
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2025, 74 (03)
  • [36] Adjuvant chemoradiotherapy (CRT) plus pembrolizumab for locally advanced esophageal squamous cell carcinoma (ESCC) with high risk of recurrence after neoadjuvant CRT plus surgery: A single-arm phase II study
    Guo, Jhe-Cyuan
    Huang, Ta-Chen
    Kuo, Hung-Yang
    Lin, Chia-Chi
    Hsu, Feng-Ming
    Cheng, Jason C.
    Huang, Yen-Lin
    Hsieh, Min-Shu
    Huang, Pei-Ming
    Lee, Jang-Ming
    Wu, Shu-Ling
    Hsu, Chih-Hung
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 320 - 320
  • [37] CRIA: Phase II Trial of Induction and Adjuvant Camrelizumab Combined with Chemoradiotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma
    Zhang, X.
    Wang, Y.
    Sui, J.
    Luo, Q.
    Lei, Q.
    Shu, X.
    Long, B.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E283 - E283
  • [38] Toripalimab combined with definitive chemoradiotherapy in locally advanced oesophageal squamous cell carcinoma (EC-CRT-001): a single-arm, phase 2 trial
    Zhu, Yujia
    Wen, Jing
    Li, Qiaoqiao
    Chen, Baoqing
    Zhao, Lei
    Liu, Shiliang
    Yang, Yadi
    Wang, Sifen
    Lv, Yingxin
    Li, Jibin
    Zhang, Li
    Hu, Yonghong
    Liu, Mengzhong
    Xi, Mian
    LANCET ONCOLOGY, 2023, 24 (04): : 371 - 382
  • [39] Neoadjuvant chemoimmunotherapy for the treatment of locally advanced laryngeal and hypopharyngeal squamous cell carcinoma: A single-arm phase 2 clinical trial.
    Chen, Yanfeng
    Yang, Ankui
    Mao, Yan-Ping
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [40] Single-arm phase II study of multiagent concurrent chemoradiotherapy and gefitinib in locoregionally advanced squamous cell carcinoma of the head and neck
    Rodriguez, Cristina P.
    Adelstein, David J.
    Rybicki, Lisa A.
    Saxton, Jerrold P.
    Lorenz, Robert R.
    Wood, Benjamin G.
    Scharpf, Joseph
    Ives, Denise I.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2012, 34 (11): : 1517 - 1523
12345